Am J Psychiatry 159:620-629, April 2002
© 2002 American Psychiatric Association
Risk Factors for 12-Month Comorbidity of Mood, Anxiety, and Substance Use Disorders: Findings From the Netherlands Mental Health Survey and Incidence Study
Ron de Graaf, Ph.D.,
Rob V. Bijl, Ph.D.,
Filip Smit, M.Sc.,
Wilma A.M. Vollebergh, Ph.D., and
J. Spijker, M.D.
OBJECTIVE: This study examined risk factor profiles of pure and comorbid 12-month mood, anxiety, and substance use disorder in the general population. METHOD: Data were derived from the Netherlands Mental Health Survey and Incidence Study, a prospective epidemiologic study in which a representative sample of 7,076 adults age 18–64 years were interviewed with the Composite International Diagnostic Interview. Logistic regression was used to compare subjects with a diagnosis of pure and comorbid disorders with nonpsychopathological comparison subjects and to compare subjects with comorbid disorders with those with pure disorder on sociodemographic characteristics, chronic somatic conditions, parental psychiatric history, and childhood traumas and adversities. RESULTS: Only 39.5% of the subjects with a 12-month mood disorder, 59.3% of those with an anxiety disorder, and 75.4% of those with a substance use disorder exhibited the disorder in the pure form. Comorbid anxiety and mood disorders, the most prevalent comorbid condition, showed associations with eight of the nine sociodemographic and long-term vulnerability factors investigated; pure mood disorder and pure anxiety disorder were each linked to only about half of the factors. Female gender, younger age, lower educational level, and unemployment were associated with comorbid anxiety and mood disorders but not with pure mood disorders. The risk profiles of pure anxiety disorder and pure substance use disorder similarly diverged from those of the comorbid conditions. CONCLUSIONS: High levels of psychiatric comorbidity exist in the general population. The risk factor profiles for comorbid disorders differ considerably from those for pure disorders. Primary prevention of secondary disorders in populations with a history of a primary disorder are important for reducing psychiatric burden.
This article has been cited by other articles:
|
|
|
|
 
M. Cerda, B. N. Sanchez, S. Galea, M. Tracy, and S. L. Buka
Estimating Co-Occurring Behavioral Trajectories Within a Neighborhood Context: A Case Study of Multivariate Transition Models for Clustered Data
Am. J. Epidemiol.,
November 15, 2008;
168(10):
1190 - 1203.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Cerda, A. Sagdeo, and S. Galea
Comorbid Forms of Psychopathology: Key Patterns and Future Research Directions
Epidemiol. Rev.,
November 1, 2008;
30(1):
155 - 177.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Sareen, A. Jagdeo, B. J. Cox, I. Clara, M. ten Have, S.-L. Belik, R. de Graaf, and M. B. Stein
Perceived Barriers to Mental Health Service Utilization in the United States, Ontario, and the Netherlands
Psychiatr Serv,
March 1, 2007;
58(3):
357 - 364.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. C. Kraemer, K. A. Wilson, and C. Hayward
Lifetime prevalence and pseudocomorbidity in psychiatric research.
Arch Gen Psychiatry,
June 1, 2006;
63(6):
604 - 608.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Langeland and W. van den Brink
Child sexual abuse and substance use disorders: role of psychiatric comorbidity
The British Journal of Psychiatry,
October 1, 2004;
185(4):
353 - 353.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. McCarter and W. Goldman
Psychopharmacology: Use of Psychotropics in Two Employee Groups Directly Affected by the Events of September 11
Psychiatr Serv,
November 1, 2002;
53(11):
1366 - 1368.
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2002
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
